Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic
Version 3 2024-06-19, 04:56Version 3 2024-06-19, 04:56
Version 2 2024-06-03, 06:56Version 2 2024-06-03, 06:56
Version 1 2021-08-30, 08:45Version 1 2021-08-30, 08:45
journal contribution
posted on 2024-06-19, 04:56authored byD Nicol, L Eckstein, M Morrison, JS Sherkow, M Otlowski, T Whitton, T Bubela, KP Burdon, D Chalmers, S Chan, J Charlesworth, C Critchley, M Crossley, S de Lacey, JL Dickinson, AW Hewitt, J Kamens, K Kato, E Kleiderman, S Kodama, J Liddicoat, DA Mackey, AJ Newson, J Nielsen, JK Wagner, Rebekah McWhirterRebekah McWhirter
Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic